{"text": ["FDA's", "Gottlieb", "blames", "industry", "'Kabuki", "drug", "pricing'", "for", "high", "costs"], "created_at": "2018-03-07 18:50:19"}
{"text": ["Biogen,", "AbbVie's", "Zinbryta,", "yanked", "from", "market,", "connected", "to", "three", "U.S.", "cases", "of", "brain", "inflammation"], "created_at": "2018-03-07 17:12:50"}
{"text": ["Zinbrynta", "Now", "Connected", "To", "Brain", "Inflammation"], "created_at": "2018-03-07 17:07:00"}
{"text": ["Zinbrynta", "Now", "Connected", "To", "Brain", "Inflammation"], "created_at": "2018-03-07 17:07:00"}
{"text": ["Why", "Gilead", "Sciences\u2019", "Harvoni", "Lost", "Market", "Share", "in", "4Q17"], "created_at": "2018-03-07 14:02:21"}
{"text": ["Gilead", "Sciences\u2019", "HCV", "Products:", "Lower", "Revenues", "in", "4Q17"], "created_at": "2018-03-07 12:33:21"}
{"text": ["Johnson", "&", "Johnson\u2019s", "Pharmaceutical", "Segment", "in", "4Q17"], "created_at": "2018-03-07 12:33:01"}
{"text": ["Europe's", "medicines", "regulator", "calls", "for", "recall", "of", "Biogen,", "AbbVie", "multiple", "sclerosis", "drug"], "created_at": "2018-03-07 10:47:59"}
